PT Actavis Indonesia (Indonesia)

PT Actavis Indonesia is a pharmaceutical company that focuses on developing, manufacturing, and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. They have a global network of operations and are the largest manufacturer of generic drugs in the world, producing 120 billion tablets and capsules a year in 80 manufacturing facilities. They have a portfolio of more than 1,800 molecules and a position in 40 markets around the world. PT Actavis Indonesia is committed to increasing access to quality health solutions and focuses on developing treatments for disorders in CNS, respiratory, oncology, and select local/regional therapeutic areas. They have developed a new 2D barcode to combat counterfeit drugs and ensure the authenticity of their products. They are dedicated to improving the lives of patients in Indonesia and around the world.